Current trials
Liver Fibrosis & Cirrhosis
Research into slowing and reversing liver scarring.
Register your interest
What is Liver Fibrosis & Cirrhosis?
Liver fibrosis is scarring of the liver caused by long-term inflammation. When scarring becomes extensive it is called cirrhosis. Clinical trials are studying medicines that aim to slow, stop or reverse the scarring process and protect remaining liver function.
Common signs and symptoms
- Often silent in early stages
- Fatigue and weakness
- Fluid retention or swelling
- Jaundice (yellowing of skin or eyes)
- Abnormal liver blood tests or scan results
- Diagnosed liver disease of any cause
Could I be eligible?
You may be suitable for a current or future research study if you:
- Are 18 years or older
- Have been diagnosed with liver fibrosis or cirrhosis
- Are under the care of a doctor for your liver
- Are interested in trials of new liver treatments
- Can attend study visits and assessments
Registering your interest does not guarantee eligibility or enrolment in a clinical trial. A member of our research team will contact you to discuss further.
Before you decide
- Independently approved
- Every study is reviewed and approved by an independent Human Research Ethics Committee before it opens to participants.
- Entirely voluntary
- You can withdraw at any time, without giving a reason, and without affecting your ongoing care.
- No referral needed
- You can register your interest yourself. We will let your treating doctor know only if you want us to.
- Questions first, decisions later
- A research coordinator talks you through what the study involves and answers your questions before you commit to anything.